The Role of Nutrition and Physical Activity in Cholesterol and Aging

Clinics in Geriatric Medicine

Volumn 31, Issue 3, 2015, Pages 401-416

  Ribeiro, Sandra Maria Lima ^a   Luz, Silmara dos Santos ^a   Aquino, Rita de Cássia ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b SÃO JUDAS TADEU UNIVERSITY   (Brazil)

Author keywords

Aging; Alzheimer disease; Atherogenesis; Cholesterol; Diet; Lipoproteins; Physical activity; Physical exercise

Indexed keywords

AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN; CHOLESTEROL; CHYLOMICRON; HIGH DENSITY LIPOPROTEIN; INTERMEDIATE DENSITY LIPOPROTEIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; MONOUNSATURATED FATTY ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; OXYSTEROL; SATURATED FATTY ACID; TRANS FATTY ACID; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; LIPOPROTEIN;

AGING; ALZHEIMER DISEASE; ATHEROSCLEROSIS; CALORIC RESTRICTION; CARDIOVASCULAR DISEASE; DIET SUPPLEMENTATION; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; EXERCISE; FAT INTAKE; GERIATRIC NUTRITION; HUMAN; HYPERCHOLESTEROLEMIA; MEDITERRANEAN DIET; PHYSICAL ACTIVITY; REVIEW; AGED; BLOOD; FEEDING BEHAVIOR; HEALTH BEHAVIOR; METABOLISM; MOTOR ACTIVITY; PHYSIOLOGY; PSYCHOLOGY;

AGED; AGING; ALZHEIMER DISEASE; ATHEROSCLEROSIS; CHOLESTEROL; FOOD HABITS; HEALTH BEHAVIOR; HUMANS; LIPOPROTEINS; MOTOR ACTIVITY;

EID: 84945495624     PISSN: 07490690     EISSN: 18798853     Source Type: Journal    
DOI: 10.1016/j.cger.2015.04.010     Document Type: Review

References (49)

1. Eckel R.H., Jakicic J.M., Ard J.D., et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013, 63(25 Pt B):2960-2984.
2. de Cardiologia S.B., Xavier H.T., Izar M.C., et al. V Diretriz Brasileira de dislipidemias e prevenção da aterosclerose. Arq Bras Cardiol 2013, 101(1):1-20.
3. Maranhão R.C., Carvalho P.O., Strunz C.C., et al. Lipoprotein (a): structure, pathophysiology and clinical implications. Arq Bras Cardiol 2014, 103(1):76-84.
4. Diffenderfer M.R., Schaefer E.J. The composition and metabolism of large and small LDL. Curr Opin Lipidol 2014, 25(3):221-226.
5. Schaefer E.J., Anthanont P., Asztalos B.F. High-density lipoprotein metabolism, composition, function, and deficiency. Curr Opin Lipidol 2014, 25(3):194-199.
6. Zarrouk A., Vejux A., Mackrill J., et al. Involvement of oxysterols in age-related diseases and ageing processes. Ageing Res Rev 2014, 18:148-162.
7. Cencioni C., Spallotta F., Mai A., et al. Sirtuin function in aging heart and vessels. J Mol Cell Cardiol 2015, [Epub ahead of print].
8. O'Flaherty M., Buchan I., Capewell S. Contributions of treatment and lifestyle to declining CVD mortality: why have CVD mortality rates declined so much since the 1960s?. Heart 2013, 99:159-162.
9. Hansson G.K. Inflammation, atherosclerosis and coronary artery disease. N Engl J Med 2005, 352(16):1685-1695.
10. Libby P., Theroux P. Pathophysiology of coronary artery disease. Circulation 2005, 111(25):3481-3488.
11. Wang J.C., Bennett M. Aging and atherosclerosis: mechanisms, functional consequences, and potential therapeutics for cellular senescence. Circ Res 2012, 111(2):245-259.
12. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356.
13. Raffai R.L., Weisgraber K.H. Cholesterol: from heart attacks to Alzheimer's disease. J Lipid Res 2003, 44(8):1423-1430.
14. Hottman D.A., Chernick D., Cheng S., et al. HDL and cognition in neurodegenerative disorders. Accumulating evidence indicates that the beneficial role of HDL extends to central nervous system. Neurobiol Dis 2014, 72(Pt A):22-36.
15. Baigent C., Keech A., Kearney P.M., et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005, 366:1267-1278.
16. Petersen L.K., Christensen K., Kragstrup J. Lipid-lowering treatment to the end? A review of observational studies and RCT on cholesterol and mortality in 80+ years old. Age Ageing 2010, 39:674-680.
17. Casiglia E., Spolaore P., Ginocchio G., et al. Predictors of mortality in very old subjects aged 80 years or over. Eur J Epidemiol 1993, 9:577-586.
18. WHO/FAO. Diet, nutrition and the prevention of chronic diseases: Report of the Joint WHO/FAO Expert Consultation. Geneva: World Health Organization; 2003 (WHO Technical Report Series 916).
19. Mellini P., Valente S., Mai A. Sirtuin modulators: an updated patent review (2012-2014). Expert Opin Ther Pat 2015, 25(1):5-15.
20. FAO/WHO Interim summary of conclusions and dietary recommendations on total fat & fatty acids from the Joint FAO/WHO Expert Consultation on Fats and Fatty Acids in Human Nutrition 2008, WHO HQ, Geneva (Switzerland).
21. Hunter J.E., Zhang J., Kris-Etherton P.M. Cardiovascular disease risk of dietary stearic acid compared with trans, other saturated, and unsaturated fatty acids: a systematic review. Am J Clin Nutr 2010, 91:46-63.
22. Mensink R.P., Zock P.L., Kester A.D., et al. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr 2003, 77:1146-1155.
23. Rohrmann S., Overvad K., Bueno-de-Mesquita H., et al. Meat consumption and mortality e results from the European Prospective Investigation into Cancer and Nutrition. BMC Med 2013, 11:63.
24. Lee J.E., McLerran D.F., Rolland B., et al. Meat intake and cause-specific mortality: a pooled analysis of Asian prospective cohort studies. Am J Clin Nutr 2013, 98:1032-1041.
25. Soedamah-Muthu S.S., Verberne L.D., Ding E.L., et al. Dairy consumption and incidence of hypertension: a dose-response meta-analysis of prospective cohort studies. Hypertension 2012, 60:1131-1137.
26. Gao D., Ning N., Wang C., et al. Dairy products consumption and risk of type 2 diabetes: systematic review and dose-response meta-analysis. PLoS One 2013, 8(9):e73965.
27. Aune D., Norat T., Romundstad P., et al. Dairy products and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of cohort studies. Am J Clin Nutr 2013, 98:1066-1083.
28. Shin J.Y., Xun P., Nakamura Y., et al. Egg consumption in relation to risk of cardiovascular disease and diabetes: a systematic review and meta-analysis. Am J Clin Nutr 2013, 98:146-159.
29. Li Y., Zhou C., Zhou X., et al. Egg consumption and risk of cardiovascular diseases and diabetes: a meta-analysis. Atherosclerosis 2013, 229:524-530.
30. Salter A.M. Dietary fatty acids and cardiovascular disease. Animal 2013, 7:163-171.
31. Hibbeln J.R., Salem N. Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy. Am J Clin Nutr 1995, 62(1):1-9.
32. Garcia-Rios A., Delgado-Lista J., Alcala-Diaz J.F., et al. Nutraceuticals and coronary heart disease. Curr Opin Cardiol 2013, 28(4):475-482.
33. Ros E. Olive oil and CVD: accruing evidence of a protective effect. Br J Nutr 2012, 108:1931-1933.
34. Oliveras-López M.J., Molina J.J., Mir M.V., et al. Extra virgin olive oil (EVOO) consumption and antioxidant status in healthy institutionalized elderly humans. Arch Gerontol Geriatr 2013, 57(2):234-242.
35. Marchioli R., Levantesi G. n-3 PUFAs in cardiovascular disease. Int J Cardiol 2013, 170:S33-S38.
36. Farvid M.S., Ding M., Pan A., et al. Dietary linoleic acid and risk of coronary heart disease: a systematic review and meta-analysis of prospective cohort studies. Circulation 2014, 130(18):1568-1578.
37. Ros E. Health benefits of nut consumption. Nutrients 2010, 2:652-682.
38. Badimon L., Vilahur G., Padro T. Nutraceuticals and atherosclerosis: human trials. Cardiovasc Ther 2010, 28(4):202-215.
39. Mente A., de Koning L., Shannon H.S., et al. A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med 2009, 169:659-669.
40. Diaz M.N., Frei B., Vita J.A., et al. Antioxidants and atherosclerotic heart disease. N Engl J Med 1997, 337:408-416.
41. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The alpha-tocopherol, beta carotene cancer prevention study group. N Engl J Med 1994, 330:1029-1035.
42. Williams R.J., Spencer J.P. Flavonoids, cognition, and dementia: actions, mechanisms, and potential therapeutic utility for Alzheimer disease. Free Radic Biol Med 2012, 52(1):35-45.
43. Bach-Faig A., Berry E.M., Lairon D., et al. Mediterranean diet pyramid today. Science and cultural updates. Public Health Nutr 2011, 12:2274-2284.
44. Sedentary Behaviour Research Network Letter to the editor: standardized use of the terms "sedentary" and "sedentary behaviours". Appl Physiol Nutr Metab 2012, 37:540-542.
45. Wilcox S., Parra-Medina D., Thompson-Robinson M., et al. Nutrition and physical activity interventions to reduce cardiovascular disease risk in health care settings: a quantitative review with a focus on women. Nutr Rev 2001, 59(7):197-215.
46. Ignarro L.J., Balestrieri M.L., Napoli C. Nutrition, physical activity, and cardiovascular disease: an update. Cardiovasc Res 2007, 73:326-340.
47. Booth F.W., Roberts C.K., Laye M.J. Lack of exercise is a major cause of chronic diseases. Compr Physiol 2012, 2(2):1143-1211.
48. Di Blasio A., Bucci I., Ripari P., et al. Lifestyle and high density lipoprotein cholesterol in postmenopause. Climacteric 2014, 17(1):37-47.
49. Henson J., Yates T., Biddle S.J., et al. Associations of objectively measured sedentary behaviour and physical activity with markers of cardiometabolic health. Diabetologia 2013, 56:1012-1020.